Visalytics
Visalytics
dismissed EB-2 (NIW) RFE Issued

Pharmacist

Pharmaceutical Service · 2025-03-31

Decision Date
2025-03-31
Location
Florida
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The petitioner proposes to operate a comprehensive pharmaceutical service providing online health services and pharmaceuticals to patients across the country. The endeavor focuses on healthcare outcomes for vulnerable populations, such as the elderly and those with chronic conditions, through medication dispensing and patient education.

Framework Evaluation

0 of 3 criteria met
1 Substantial Merit and National Importance Not Met

The endeavor has substantial merit but lacks evidence of national importance or substantial positive economic effects.

Why This Petition Was Denied

The appeal was dismissed because the petitioner failed to establish the national importance of the endeavor under the first Dhanasar prong. Although the business plan projected revenue of $130M to $281M and the creation of 20 jobs by year 5, these figures were not corroborated with evidence showing substantial economic impact beyond the local level.

Request for Evidence (RFE)

Unsuccessfully Addressed

The Director issued an RFE regarding the national importance of the endeavor; the petitioner responded with details on medication dispensing and wellness programs.

RFE Targets
Substantial Merit and National Importance

Evidence

Evidence Types
Reference Letters Dependent
Original Contributions

Similar Cases

Pharmacist

Pharmaceuticals · Brazil

USCIS EB-2 (NIW) rfe dismissed
Florida 2024-07-11
The petitioner proposes to develop a business providing wellness products and health consultation services, eventually opening a compounding pharmacy in Florida. The endeavor focuses on researching and developing natural, formula-based products to treat health issues such as sexual health, weight loss, anxiety, and stress.

Chief Executive Officer (CEO)

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Florida 2024-04-19
The petitioner proposes to launch and develop a Florida-based company focused on a digital learning and instruction platform for pharmaceutical sales professionals. The endeavor involves coaching sales teams and developing commercial chains for American products, specifically in ophthalmology-related pharmaceuticals, to help U.S. companies reach international markets.

Pharmacist

Healthcare

USCIS EB-2 (NIW) rfe dismissed
Texas 2024-04-19
The petitioner initially proposed to work as a pharmacist in community clinics. Later, she attempted to change her endeavor to establishing a medication management business for the elderly using a software application and a bracelet device.

Others

Healthcare

USCIS EB-2 (NIW) rfe dismissed
2024-06-28
The petitioner proposes to establish and operate pharmacies within the United States. The endeavor involves the implementation of a business plan to provide pharmaceutical services.

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Pharmaceuticals cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-31.

Browse all cases

At a Glance

Outcome dismissed
RFE Issued
Criteria Met 0 / 3
Evidence Types 2

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist